Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Lexaria Bioscience Corp. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 16 | 16 | 0 |
| Shares | 561.7K | 687.7K | +125.9K (+22.4%) |
| Value | $1.67M | $1.68M | +$10.0K (+0.6%) |
New holders (3)
Institutions that held Lexaria Bioscience Corp. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 40,119 | $98.0K | 0.00% |
| Dimensional Fund Advisors LP | 15,264 | $37.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,628 | $9.00K | 0.00% |
Sold out (3)
Institutions that held Lexaria Bioscience Corp. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Merit Financial Group, LLC | 21,267 | $63.0K |
| Virtu Financial LLC | 10,975 | $33.0K |
| Citigroup Inc | 1,230 | $4.00K |